Cancer Family
Malignant Thoracic Neoplasm
CI-CAN-00000256Explore in graph →
2,775 active trials51 approved drugs626 evidence items
- NCIt
- C3576
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000256Explore in graph →
Clinical trials
11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,528)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01683175 | Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation | unknown | Phase 2 | 94 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 20, 2016 | clinicaltrials |
| NCT02936804 | Precision Diagnosis and Therapy for Early Stage Lung Cancer | unknown | N/A | 60,000 | Shanghai Chest HospitalOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT02013063 |
| Single Pulmonary Nodule Investigation(SPUtNIk) |
| unknown |
| — |
| 375 |
| University Hospital Southampton NHS Foundation TrustOTHER |
| 1 |
| Oct 18, 2016 |
| clinicaltrials |
| NCT02930954 | Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance | unknown | Phase 2 | 180 | Caicun ZhouOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT02906384 | Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) | unknown | Phase 2 | 154 | Zhejiang Cancer HospitalOTHER | 1 | Oct 10, 2016 | clinicaltrials |
| NCT02873416 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT01771289 | Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC | unknown | Phase 2 | 50 | Peking University People's HospitalOTHER | 1 | Sep 27, 2016 | clinicaltrials |
| NCT02916147 | Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy | unknown | N/A | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Sep 27, 2016 | clinicaltrials |
| NCT02507778 | Circulating Tumor Cells Spillage After Pulmonary Biopsy | unknown | N/A | 40 | Rabin Medical CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02913365 | Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis | unknown | — | 1,000 | Université de SherbrookeOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02360761 | Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy(STEPS) | unknown | Phase 3 | 339 | Peking University People's HospitalOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02907606 | Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study | unknown | — | 45 | Peking University People's HospitalOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02904850 | Validation of a Kinetic Model of Erlotinib | unknown | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02906150 | Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type | unknown | Phase 2 | 140 | SciClone PharmaceuticalsINDUSTRY | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02906163 | First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy | unknown | Phase 1 / Phase 2 | 188 | SciClone PharmaceuticalsINDUSTRY | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02898441 | Early Stage Lung Cancer Screening With Low-dose Computed Tomographic | unknown | N/A | 6,000 | Shanghai Chest HospitalOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT02898857 | Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma(NOTCH) | unknown | — | 18 | University Hospital, MontpellierOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT02862587 | Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer | unknown | Phase 1 / Phase 2 | 40 | Shanghai International Medical CenterINDUSTRY | 1 | Sep 2, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02802540 | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients | unknown | Phase 2 / Phase 3 | 78 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02883543 | First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation | unknown | Phase 3 | 330 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 0 | Aug 30, 2016 | clinicaltrials |
| NCT02879097 | Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC | unknown | Phase 3 | 200 | Cipla BioTec Pvt. Ltd.INDUSTRY | 0 | Aug 25, 2016 | clinicaltrials |
| NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | unknown | Phase 3 | 100 | Third Military Medical UniversityOTHER | 0 | Aug 24, 2016 | clinicaltrials |
| NCT02876978 | Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma | unknown | Phase 1 | 20 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02877043 | Study of the Quality of Lung Resection(ResPul) | unknown | — | 72,000 | Centre Hospitalier Universitaire DijonOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02859077 | EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism | unknown | Phase 3 | 100 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 0 | Aug 9, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01460472 | Immunotherapy With Racotumomab in Advanced Lung Cancer | unknown | Phase 3 | 1,082 | Recombio SLINDUSTRY | 7 | Jul 29, 2016 | clinicaltrials |
| NCT01576796 | Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer(RTEP-5) | unknown | Phase 2 | 75 | Centre Henri BecquerelOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT02843711 | Molecular Analysis of 150 Lung Adenocarcinoma(LUNG-EST) | unknown | — | 152 | Hospices Civils de LyonOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02841228 | Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer | unknown | Phase 2 | 40 | Hunan Province Tumor HospitalOTHER | 1 | Jul 22, 2016 | clinicaltrials |
| NCT01637597 | Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation | unknown | — | 12 | National Taiwan University HospitalOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT00697333 | Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC(PET-Plan) | unknown | Phase 2 | 200 | Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGNOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02820116 | The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation | unknown | Phase 2 | 67 | Beijing Haidian HospitalOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT02439073 | Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA)(PROLUCA) | unknown | N/A | 235 | Rigshospitalet, DenmarkOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02804217 | Acquired Resistant Mechanism of the First-generation EGFR TKIs | unknown | — | 60 | Zhejiang Cancer HospitalOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02804646 | Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma | unknown | Phase 4 | 100 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02803619 | A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis | unknown | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Jun 17, 2016 | clinicaltrials |
| NCT02105168 | Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment(MSN) | unknown | N/A | 2,200 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02788058 | A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | unknown | Phase 2 | 76 | First People's Hospital of HangzhouOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT01882621 | Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02651441 | D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 1 / Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02778893 | Conmana Combined With Thalidomide to Treat NSCLC | unknown | Phase 4 | 67 | Henan Provincial People's HospitalOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT01745445 | Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)(SCLC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02772107 | Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 132 | Chinese PLA General HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT01892800 | Right Side of Heart Function After Lung Surgery | unknown | — | 25 | University of GlasgowOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT02771756 | The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy | unknown | N/A | 300 | Chinese Academy of Medical SciencesOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT02766348 | Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 9, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Oct 20, 2016source: clinicaltrials